Jc. Bevan et al., REVERSAL OF DOXACURIUM AND PANCURONIUM NEUROMUSCULAR BLOCKADE WITH NEOSTIGMINE IN CHILDREN, Canadian journal of anaesthesia, 41(11), 1994, pp. 1074-1080
Recovery after doxacurium and pancuromium neuromuscular blockade and t
heir acceleration by neostigmine have not been compared in children. T
herefore, 60 paediatric surgical patients aged 2-10 yr (ASA 1-2) were
studied. They were randomized to receive doxacurium 30 mu g . kg(-1) o
r pancuronium 70 mu g . kg(-1) iv during propofol, fentanyl, isofluran
e and nitrous oxide anaesthesia. Electromyographic (EMG) responses of
the adductor pollicis to train-of-four (TOF) stimulation of the ulnar
nerve were recorded every ten seconds using a Datex NMT monitor. Six p
atients in each relaxant group received neostigmine (0, 5, 10, 20 and
40 mu . kg(-1)) with atropine by random allocation when first twitch h
eight (T-1) had recovered to 25% of control. Spontaneous recovery afte
r ten minutes was similar following doxacurium (mean +/- SEM values of
45.0 +/- 3.9 vs 49.5 +/- 10.0% for T-1 and 25.2 +/- 3.8 vs 14.8 +/- 3
.6% for TOF ratios ). Dose responses to neostigmine were calculated fr
om the log dose vs logit of T-1 or TOF ratio after ten minutes. Neosti
gmine-assisted recovery was not different in the two groups, with ED(7
0) and ED(90) doses for T-1 of 14.3 +/- 1.8 and 25.7 +/- 2.7 mu g . kg
(-1) for doxacurium and 12.5 +/- 1.7 and 25.3 +/- 2.3 mu g . kg(-1) fo
r pancuronium. Time to recovery of TOF ratio to 70% after neostigmine
40 mu . kg(-1) was 2.3 +/- 1.0 and 4.2 +/- 1.7 min (P = NS) following
pancuronium and doxacurium, respectively. Adjusted recovery due to neo
stigmine alone (spontaneous recovery subtracted from the total) requir
ed two to three times higher doses of neostigmine. Thus, in children,
the spontaneous recovery and reversal of neuromuscular blockade is sim
ilar with doxacurium and pancuronium. However, compared with previous
adult studies, they recover twice as quickly from doxacurium neuromusc
ular blockade and neostigmine antagonism is achieved at 25-50% of the
adult doses.